COLL stock: buy or sell?

COLL stock price: $21.68 -3.94% At close on February 27th, 2020

Updated on:
February 27th, 2020


Shares of Collegium Pharmaceutical collapsed a frightening -3.94% and closed at $21.68. With Thursday it's been 4 sliding days in a row, loosing $-2.25 (-9.53%).

Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes abuse-deterrent products that incorporate its DETERx platform technology for the treatment of chronic pain and other diseases.

Should I buy COLL stock?

Trading stocks requires experience and discipline, and your buying and selling decisions must come following a methodology. Following a trading strategy helps to make decisions easier, quicker and with less hesitations. At, we use very simple but trusted and powerful trend following trading strategies. Simple things usually work the best.

Currently, Collegium Pharmaceutical stock doesn't match any of these trading strategies, so our recommendation is not to buy.

Buy setupElegible
New all-time highNo
New 52 week highNo
Price crossing up 200d MANo
100d MA crossing up 200d MANo
This doesn't mean COLL will fall in coming sessions, or it will not rise higher. Simply, it doesn't match our recommended trading systems.

Is Collegium Pharmaceutical stock a buy?

Everyday, hundreds of stock ratings are published by financial analysts to indicate a particular stock's attractiveness. Unfortunately, we couldn't detect any rating for COLL stock for the last month.

COLL stock analysis

Daily outlook

Collegium Pharmaceutical shares collapsed -3.94% to $21.68 today.

Collegium Pharmaceutical collapsed a frightening -3.94% and closed at $21.68. Since SMA100d and SMA200d crossed up on December, COLL price climbed $0.73 per share (3.48%). Since last November when COLL stock price broke up the SMA200d line, it gained $8.83 (68.72%).

COLL stock chart (daily)

Weekly outlook

Shares of Collegium Pharmaceutical closed this week at $21.68 and plunged a scary -9.40%. Early February COLL skyrocketed a super good 20.94% in just one week.

In a weekly time frame, Collegium Pharmaceutical stock is drawing an uptrend with rising tops and bottoms. Now trading in between its last bottom and last top, COLL might consolidate in a flat-base, waiting to break out over or down under . Early December, SMA20w and SMA40w crossed up triggering a rise of 2.94%. Since early November 2019 when COLL stock price broke up the SMA40w line, it gained $8.83 (68.72%).

COLL stock chart (weekly)

COLL stock price history

COLL IPO was on May 7th, 2015 at $12.00 per share1. Since then, COLL stock grew a 80.70%, with an average of 20.20% per year. If you had invested right after COLL's IPO a $1,000 in COLL stock in 2015, it would worth $807.00 today.

1: Adjusted price after possible price splits or reverse-splits.

COLL stock historical price chart

COLL stock reached 52-week highs on February 7th at $25.59, and all-time highs 2015-12-30 with a price of 30.58.

COLL stock price target

How much a stock will be priced tomorrow or next week is quite unpredictable However, banks and other financial institutions analysts, with the help of lots of data and algorithms do their best to predict the stock prices movement. You should not follow the analysts' COLL stock price predictions in the hope that they will be met as they may be wrong and not met. For the last 30 days we have not found any price target for Collegium Pharmaceutical stock by any trusted analyst.

Financials and fundamental analysis

Earnings date and Earnings per Share

, when Collegium Pharmaceutical presented its last earnings report, it . As soon as we get its posted EPS from the earnings report, we will update this review.
COLL earnings date and EPS evolution
QuarterReporting dateEstimated EPSActual EPSSurprise

Annual financial results

In 2018, Collegium Pharmaceutical annual turnover climbed an extraordinary 884.73% to $280.41 M dollars from $28.48 marked in 2017. When comparing 2018 vs 2017, likewise, profit margin (that is, the net income divided by revenues) climbed a 248.95% to -13.95%.

COLL annual Sales and Income evolution
2016$1.71 M-$-94.18 M-5504.1%-
2017$28 M1,564.29%$-74.87 M-262.9%-20.51%
2018$280 M884.73%$-39.13 M-14.0%-47.74%

Quarterly financial results

Collegium Pharmaceutical posted $73.43 million in revenues for 2018-Q4, a 4.63% improvement compared to previous quarter. Reported quarter income marked $9.09 million with a profit margin of 12.37%. Profit margin rocketed a 35.89% compared to previous quarter when profit margin was -23.52%. When comparing revenues to same quarter last year, Collegium Pharmaceutical sales marked an astounding growth and boosted a 580.26%.
COLL quarterly Sales and Income evolution
2017-Q1$2 M-$-23.08 M-1063.6%-
2017-Q2$4 M64.06%$-21.12 M-593.3%-8.49%
2017-Q3$12 M235.67%$-13.26 M-111.0%-37.20%
2017-Q4$11 M-9.67%$-17.40 M-161.2%31.21%
2018-Q1$64 M490.60%$-18.65 M-29.3%7.18%
2018-Q2$73 M14.61%$-13.06 M-17.9%-29.98%
2018-Q3$70 M-3.95%$-16.50 M-23.5%26.36%
2018-Q4$73 M4.63%$9.09 M12.4%-155.06%

Collegium Pharmaceutical ownership

When you are planning to buy a stock, it's always worth to review its ownership structure.

Management staff in all public traded companies that hold equity is required to report every transaction to the SEC. For Collegium Pharmaceutical, 2.06% of all outstanding shares are owned by its staff.

Bearish positions for COLL stock account 0.00%, no big difference from last month.

The following table compares ownership indicators for other stocks related to Collegium Pharmaceutical:

Market cap$726.9 M
Total shares33.5 M
Float shares32.9 M
  - Institutional holdings (%)99.8%
  - Insider holdings (%)2.1%
Shares in short selling0.0%

COLL summary

Thursday, February 27th, 2020
Day range$21.61 - $22.47
Previous close$22.57
Session gain-3.94%
Average true range$1.78
50d mov avg$21.78
100d mov avg$19.01
200d mov avg$15.31
Daily pattern
Weekly pattern lt06a

Collegium Pharmaceutical performance

Stocks performance is always measured in comparision to the market or competitors and related stocks in the same industry. We picked as the bechmarking frame for Collegium Pharmaceutical stock.
COLLCollegium Pharmac...-0.23%87.22%18.53%

Collegium Pharmaceutical competitors

Unfortunately, we could not find any public company that could be defined as Collegium Pharmaceutical competitor. This doesn't mean Collegium Pharmaceutical does not have any competitor in the market, it's just we could not detected it.